- Conditions
- Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +32 more
- Locations
-
- UCSF Comprehensive Cancer Center San Francisco, California, United States
Clinical trial condition
Leukemia
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
1,702 public trials
178 recruiting studies
Leukemia trial results
NCT00295971
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
NCT01723657
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
- Locations
-
- Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
- Hospital del Mar Barcelona, Spain
- Centro Medico Teknon Barcelona, Spain
- Hospital de la Santa Creu i Sant Pau Barcelona, Spain
Completed
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
NCT00900406
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +58 more
- Locations
-
- Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT00005622
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT00255749
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +64 more
- Locations
-
- Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
NCT00296023
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
- Locations
-
- Alta Bates Comprehensive Cancer Center Berkeley, California, United States
- UCSF Comprehensive Cancer Center San Francisco, California, United States
NCT00787761
- Conditions
- Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
- Locations
-
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
Completed
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
NCT00005793
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
NCT00005626
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States